Prognostic features of patients with myelodysplastic syndromes aged < 50 years: update of a single-institution experience
Authors:
- Massimo BrecciaMassimo Breccia
- Paola FinsingerPFPaola Finsinger
- Giuseppina LoglisciGLGiuseppina Loglisci
- Michelina SantopietroMSMichelina Santopietro
- Adriano SalaroliASAdriano Salaroli
- Alessandra SerraoASAlessandra Serrao
- Roberto LatagliataRLRoberto Latagliata
- Paola VolpicelliPVPaola Volpicelli
- Luigi PetrucciLPLuigi Petrucci
- Mauro NanniMNMauro Nanni
- Giuliana AlimenaGAGiuliana Alimena
- 9 July 2012
- journal article
- Published by Taylor & Francis in Leukemia & Lymphoma
- Vol. 53 (12) , 2439-2443
Abstract
Less than 10% of MDS patients are younger than 50 years. A series of 91 younger patients (median age 44 years with female prevalence) are reported and compared with elderly patients. Frequent karyotypic changes were trisomy 8 (10.5%) and monosomy 7 (5%). Twenty-three patients had occupational exposure to potential mutagens (benzene and solvents), with a male predominance, higher frequency of RCMD (52%) and higher frequency of monosomy 7 (13%). At a median follow-up of 72 months, 22 patients (24%) evolved to acute leukemia with higher frequency being observed among the exposed cohort (39% vs 19% of non-exposed). Unfavorable factors for overall survival were: age > 40 years, >5% of blasts and trilinear bone marrow involvement, intermediate-high WPSS risk. Present results suggest that younger MDS could be identified as a distinct subset: for patients belonging to low/intermediate-I risk, due to low transformation rate, aggressive approaches should rarely be recommendedKeywords
This publication has 16 references indexed in Scilit:
- Epidemiological data on myelodysplastic syndrome patients under 50 years in a single center of RomaniaLeukemia Research, 2010
- Myelodysplastic Syndromes Classification and Risk StratificationHematology/Oncology Clinics of North America, 2010
- The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changesBlood, 2009
- Proposal for a new risk model in myelodysplastic syndrome that accounts for events not considered in the original International Prognostic Scoring SystemCancer, 2008
- Time-Dependent Prognostic Scoring System for Predicting Survival and Leukemic Evolution in Myelodysplastic SyndromesJournal of Clinical Oncology, 2007
- Myelodysplastic Syndromes in Patients Younger Than Age 50Journal of Clinical Oncology, 2006
- Myelodysplastic syndromes in patients under 50 years old: a single institution experienceLeukemia Research, 2005
- Primary myelodysplasia occurring in adults under 50 years old: a clinicopathologic study of 52 patientsLeukemia, 2002
- De novo myelodysplastic syndromes in adults aged 50 or less. A report on 37 casesLeukemia Research, 1990
- Proposals for the classification of the myelodysplastic syndromesBritish Journal of Haematology, 1982